메뉴 건너뛰기




Volumn 31, Issue 2, 2008, Pages 143-158

Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: A cohort study using pharmacy dispensing data in the Netherlands

Author keywords

Cardiovascular disorders; Cyclo oxygenase 2 inhibitors, adverse reactions; Gastrointestinal disorders; Nonsteroidal anti inflammatories, adverse reactions; Risk factors

Indexed keywords

CELECOXIB; DICLOFENAC; IBUPROFEN; KETOPROFEN; MELOXICAM; NABUMETONE; NAPROXEN; PIROXICAM; ROFECOXIB; VALDECOXIB;

EID: 38549179823     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831020-00004     Document Type: Article
Times cited : (37)

References (58)
  • 1
    • 0025805153 scopus 로고
    • Channeling bias in the interpretation of drug effects
    • Apr;
    • Petri H, Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 1991 Apr; 10 (4): 577-81
    • (1991) Stat Med , vol.10 , Issue.4 , pp. 577-581
    • Petri, H.1    Urquhart, J.2
  • 2
    • 0030760118 scopus 로고    scopus 로고
    • A study of the longitudinal utilization and switching-patterns of non-steroidal anti-inflammatory drugs using a pharmacy based approach
    • Jul;
    • Sift R, van Staa TP, Abenhaim L, et al. A study of the longitudinal utilization and switching-patterns of non-steroidal anti-inflammatory drugs using a pharmacy based approach. Pharmacoepidemiol Drug Saf 1997 Jul; 6 (4): 263-8
    • (1997) Pharmacoepidemiol Drug Saf , vol.6 , Issue.4 , pp. 263-268
    • Sift, R.1    van Staa, T.P.2    Abenhaim, L.3
  • 3
    • 0026644458 scopus 로고
    • Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems
    • Aug;
    • Leufkens HG, Urquhart J, Stricker BH, et al. Channelling of controlled release formulation of ketoprofen (Oscorel) in patients with history of gastrointestinal problems. J Epidemiol Community Health 1992 Aug; 46 (4): 428-32
    • (1992) J Epidemiol Community Health , vol.46 , Issue.4 , pp. 428-432
    • Leufkens, H.G.1    Urquhart, J.2    Stricker, B.H.3
  • 4
    • 0034083748 scopus 로고    scopus 로고
    • The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: Cohort study
    • Jul;
    • Martin RM, Biswas P, Mann RD. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study. Br J Clin Pharmacol 2000 Jul; 50 (1): 35-42
    • (2000) Br J Clin Pharmacol , vol.50 , Issue.1 , pp. 35-42
    • Martin, R.M.1    Biswas, P.2    Mann, R.D.3
  • 5
    • 0041885420 scopus 로고    scopus 로고
    • Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
    • Sep;
    • MacDonald TM, Morant SV, Goldstein JL, et al. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003 Sep; 52 (9): 1265-70
    • (2003) Gut , vol.52 , Issue.9 , pp. 1265-1270
    • MacDonald, T.M.1    Morant, S.V.2    Goldstein, J.L.3
  • 7
    • 0031004839 scopus 로고    scopus 로고
    • Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment
    • Jun;
    • Egberts AC, Lenderink AW, de Koning FH, et al. Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment. J Clin Psychopharmacol 1997 Jun; 17 (3): 149-55
    • (1997) J Clin Psychopharmacol , vol.17 , Issue.3 , pp. 149-155
    • Egberts, A.C.1    Lenderink, A.W.2    de Koning, F.H.3
  • 8
    • 0023077226 scopus 로고
    • Non-steroidal anti-inflammatory drugs: Assessment of risks
    • Inman WH. Non-steroidal anti-inflammatory drugs: assessment of risks. Eur J Rheumatol Inflamm 1987; 8 (1): 71-85
    • (1987) Eur J Rheumatol Inflamm , vol.8 , Issue.1 , pp. 71-85
    • Inman, W.H.1
  • 9
    • 0035833502 scopus 로고    scopus 로고
    • The coxibs, selective inhibitors of cyclooxygenase-2
    • Aug 9;
    • FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001 Aug 9; 345 (6): 433-42
    • (2001) N Engl J Med , vol.345 , Issue.6 , pp. 433-442
    • FitzGerald, G.A.1    Patrono, C.2
  • 10
    • 22244446152 scopus 로고    scopus 로고
    • The trade-off between cardiovascular and gastrointestinal effects of rofecoxib
    • Jul;
    • Florentinus SR, Heerdink ER, de BA, et al. The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. Pharmacoepidemiol Drug Saf 2005 Jul; 14 (7): 437-41
    • (2005) Pharmacoepidemiol Drug Saf , vol.14 , Issue.7 , pp. 437-441
    • Florentinus, S.R.1    Heerdink2    ER, D.B.3
  • 11
    • 1542516241 scopus 로고    scopus 로고
    • Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland
    • Mar;
    • Girvin B, Rafferty T, Stevenson MR, et al. Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland. Pharmacoepidemiol Drug Saf 2004 Mar; 13 (3): 153-7
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , Issue.3 , pp. 153-157
    • Girvin, B.1    Rafferty, T.2    Stevenson, M.R.3
  • 12
    • 2342489871 scopus 로고    scopus 로고
    • Upper gastrointestinal bleeding associated with the use of NSAIDs: Newer versus older agents
    • Laporte JR, Ibanez L, Vidal X, et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 2004; 27 (6): 411-20
    • (2004) Drug Saf , vol.27 , Issue.6 , pp. 411-420
    • Laporte, J.R.1    Ibanez, L.2    Vidal, X.3
  • 13
    • 28544433318 scopus 로고    scopus 로고
    • Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis
    • Dec 3;
    • Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005 Dec 3; 331 (7528): 1310-6
    • (2005) BMJ , vol.331 , Issue.7528 , pp. 1310-1316
    • Hippisley-Cox, J.1    Coupland, C.2    Logan, R.3
  • 14
    • 0034707105 scopus 로고    scopus 로고
    • Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000 Nov 23; 343 (21): 1520-8, 2
    • Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000 Nov 23; 343 (21): 1520-8, 2
  • 15
    • 31044441042 scopus 로고    scopus 로고
    • Biological basis for the cardiovascular consequences of COX-2 inhibition: Therapeutic challenges and opportunities
    • Jan;
    • Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006 Jan; 116 (1): 4-15
    • (2006) J Clin Invest , vol.116 , Issue.1 , pp. 4-15
    • Grosser, T.1    Fries, S.2    FitzGerald, G.A.3
  • 16
    • 14844337012 scopus 로고    scopus 로고
    • Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
    • Mar 14;
    • Aw TJ, Haas SJ, Liew D, et al. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med 2005 Mar 14; 165 (5): 490-6
    • (2005) Arch Intern Med , vol.165 , Issue.5 , pp. 490-496
    • Aw, T.J.1    Haas, S.J.2    Liew, D.3
  • 17
    • 0036140865 scopus 로고    scopus 로고
    • Incidence of serious upper gastrointestinal bleeding/perforation in the general population: Review of epidemiologic studies
    • Feb;
    • Hernandez-Diaz S, Rodriguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. J Clin Epidemiol 2002 Feb; 55 (2): 157-63
    • (2002) J Clin Epidemiol , vol.55 , Issue.2 , pp. 157-163
    • Hernandez-Diaz, S.1    Rodriguez, L.A.2
  • 19
    • 2542477738 scopus 로고    scopus 로고
    • Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs
    • May;
    • Zhao SZ, Wentworth C, Burke TA, et al. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiol Drug Saf 2004 May; 13 (5): 277-87
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , Issue.5 , pp. 277-287
    • Zhao, S.Z.1    Wentworth, C.2    Burke, T.A.3
  • 20
    • 12444258696 scopus 로고    scopus 로고
    • National trends in cyclooxygenase-2 inhibitor use since market release: Nonselective diffusion of a selectively cost-effective innovation
    • Jan 24;
    • Dai C, Stafford RS, Alexander GC. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation. Arch Intern Med 2005 Jan 24; 165 (2): 171-7
    • (2005) Arch Intern Med , vol.165 , Issue.2 , pp. 171-177
    • Dai, C.1    Stafford, R.S.2    Alexander, G.C.3
  • 21
    • 27644498521 scopus 로고    scopus 로고
    • Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs
    • Jul;
    • Helin-Salmivaara A, Huupponen R, Virtanen A, et al. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2005 Jul; 61 (5-6): 425-31
    • (2005) Eur J Clin Pharmacol , vol.61 , Issue.5-6 , pp. 425-431
    • Helin-Salmivaara, A.1    Huupponen, R.2    Virtanen, A.3
  • 22
    • 33644651336 scopus 로고    scopus 로고
    • Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: A population-based case-control study
    • Moride Y, Ducruet T, Boivin JF, et al. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Arthritis Res Ther 2005; 7 (2): R333-42
    • (2005) Arthritis Res Ther , vol.7 , Issue.2
    • Moride, Y.1    Ducruet, T.2    Boivin, J.F.3
  • 23
    • 1942470118 scopus 로고    scopus 로고
    • COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: A population-based case-control study
    • Apr 1;
    • Norgard B, Pedersen L, Johnsen SP, et al. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Aliment Pharmacol Ther 2004 Apr 1; 19 (7): 817-25
    • (2004) Aliment Pharmacol Ther , vol.19 , Issue.7 , pp. 817-825
    • Norgard, B.1    Pedersen, L.2    Johnsen, S.P.3
  • 24
    • 2442438559 scopus 로고    scopus 로고
    • Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease
    • Apr;
    • Joshua FF, Oakley SP, Major GA. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Intern Med J 2004 Apr; 34 (4): 153-61
    • (2004) Intern Med J , vol.34 , Issue.4 , pp. 153-161
    • Joshua, F.F.1    Oakley, S.P.2    Major, G.A.3
  • 25
    • 33747874024 scopus 로고    scopus 로고
    • Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs
    • Aug 15;
    • Mosis G, Stijnen T, Castellsague J, et al. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs. Arthritis Rheum 2006 Aug 15; 55 (4): 537-42
    • (2006) Arthritis Rheum , vol.55 , Issue.4 , pp. 537-542
    • Mosis, G.1    Stijnen, T.2    Castellsague, J.3
  • 26
    • 33646235891 scopus 로고    scopus 로고
    • Linking community pharmacy dispensing data to prescribing data of general practitioners
    • Florentinus SR, Souverein PC, Griens FA, et al. Linking community pharmacy dispensing data to prescribing data of general practitioners. BMC Med Inform Decis Mak 2006; 6: 18
    • (2006) BMC Med Inform Decis Mak , vol.6 , pp. 18
    • Florentinus, S.R.1    Souverein, P.C.2    Griens, F.A.3
  • 27
    • 0002656782 scopus 로고    scopus 로고
    • Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs
    • Jan 12;
    • Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, et al. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998 Jan 12; 158 (1): 33-9
    • (1998) Arch Intern Med , vol.158 , Issue.1 , pp. 33-39
    • Garcia Rodriguez, L.A.1    Cattaruzzi, C.2    Troncon, M.G.3
  • 28
    • 0032558285 scopus 로고    scopus 로고
    • North of England evidence based guideline development project: Summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group
    • Aug 22;
    • Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. BMJ 1998 Aug 22; 317 (7157): 526-30
    • (1998) BMJ , vol.317 , Issue.7157 , pp. 526-530
    • Eccles, M.1    Freemantle, N.2    Mason, J.3
  • 29
    • 0035112660 scopus 로고    scopus 로고
    • Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
    • Feb;
    • Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001 Feb; 120 (3): 594-606
    • (2001) Gastroenterology , vol.120 , Issue.3 , pp. 594-606
    • Laine, L.1
  • 30
    • 33749536913 scopus 로고    scopus 로고
    • Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications
    • Hernandez-Diaz S, Garcia Rodriguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 2006; 4: 22
    • (2006) BMC Med , vol.4 , pp. 22
    • Hernandez-Diaz, S.1    Garcia Rodriguez, L.A.2
  • 31
    • 0033598594 scopus 로고    scopus 로고
    • Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study
    • Oct 23;
    • de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999 Oct 23; 319 (7217): 1106-9
    • (1999) BMJ , vol.319 , Issue.7217 , pp. 1106-1109
    • de Abajo, F.J.1    Rodriguez, L.A.2    Montero, D.3
  • 32
    • 0026548664 scopus 로고
    • A chronic disease score from automated pharmacy data
    • Feb;
    • Von-Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992 Feb; 45 (2): 197-203
    • (1992) J Clin Epidemiol , vol.45 , Issue.2 , pp. 197-203
    • Von-Korff, M.1    Wagner, E.H.2    Saunders, K.3
  • 33
    • 0029351501 scopus 로고    scopus 로고
    • A chronic disease score with empirically derived weights
    • Aug 1;
    • Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Med Care 2005 Aug 1; 8: 783-98
    • (2005) Med Care , vol.8 , pp. 783-798
    • Clark, D.O.1    Von Korff, M.2    Saunders, K.3
  • 34
    • 33845608746 scopus 로고    scopus 로고
    • Use of cyclooxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    • Dec;
    • Arellano FM, Yood MU, Wentworth CE, et al. Use of cyclooxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf 2006 Dec; 15 (12): 861-72
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , Issue.12 , pp. 861-872
    • Arellano, F.M.1    Yood, M.U.2    Wentworth, C.E.3
  • 35
    • 0037329150 scopus 로고    scopus 로고
    • Safety profile of rofecoxib as used in general practice in England: Results of a prescription-event monitoring study
    • Layton D, Riley J, Wilton LW, et al. Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study. Br J Clin Pharmacol 2002; 55: 166-74
    • (2002) Br J Clin Pharmacol , vol.55 , pp. 166-174
    • Layton, D.1    Riley, J.2    Wilton, L.W.3
  • 36
    • 5344235403 scopus 로고    scopus 로고
    • Safety profile of celecoxib as used in general practice in England: Results of a prescription-event monitoring study
    • Sep;
    • Layton D, Wilton LV, Shakir SA. Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study. Eur J Clin Pharmacol 2004 Sep; 60 (7): 489-501
    • (2004) Eur J Clin Pharmacol , vol.60 , Issue.7 , pp. 489-501
    • Layton, D.1    Wilton, L.V.2    Shakir, S.A.3
  • 37
    • 0035698427 scopus 로고    scopus 로고
    • Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: A retrospective cohort study of a general practitioners database in the United Kingdom
    • Oct;
    • Langman M, Kahler KH, Kong SX, et al. Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom. Pharmacoepidemiol Drug Saf 2001 Oct; 10 (6): 517-24
    • (2001) Pharmacoepidemiol Drug Saf , vol.10 , Issue.6 , pp. 517-524
    • Langman, M.1    Kahler, K.H.2    Kong, S.X.3
  • 38
    • 18344390561 scopus 로고    scopus 로고
    • Are cyclooxygenase-2 inhibitors being taken only by those who need them?
    • May 9;
    • Kaufman DW, Kelly JP, Rosenberg L, et al. Are cyclooxygenase-2 inhibitors being taken only by those who need them? Arch Intern Med 2005 May 9; 165 (9): 1066-7
    • (2005) Arch Intern Med , vol.165 , Issue.9 , pp. 1066-1067
    • Kaufman, D.W.1    Kelly, J.P.2    Rosenberg, L.3
  • 39
    • 32544433650 scopus 로고    scopus 로고
    • Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib?
    • Feb 15;
    • Rahme E, Hunsche E, Toubouti Y, et al. Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: what is the potential impact of the withdrawal of rofecoxib? Arthritis Rheum 2006 Feb 15; 55 (1): 27-34
    • (2006) Arthritis Rheum , vol.55 , Issue.1 , pp. 27-34
    • Rahme, E.1    Hunsche, E.2    Toubouti, Y.3
  • 40
    • 0347418227 scopus 로고    scopus 로고
    • Determinants of selective cyclooxygenase-2 inhibitor prescribing: Are patient or physician characteristics more important?
    • Dec 15;
    • Solomon DH, Schneeweiss S, Glynn RJ, et al. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med 2003 Dec 15; 115 (9): 715-20
    • (2003) Am J Med , vol.115 , Issue.9 , pp. 715-720
    • Solomon, D.H.1    Schneeweiss, S.2    Glynn, R.J.3
  • 41
    • 33749339372 scopus 로고    scopus 로고
    • Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
    • Oct 4;
    • McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006 Oct 4; 296 (13): 1633-44
    • (2006) JAMA , vol.296 , Issue.13 , pp. 1633-1644
    • McGettigan, P.1    Henry, D.2
  • 42
    • 0036208570 scopus 로고    scopus 로고
    • Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease
    • Feb;
    • Visser LE, Graatsma HH, Stricker BH. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 2002 Feb; 53 (2): 183-8
    • (2002) Br J Clin Pharmacol , vol.53 , Issue.2 , pp. 183-188
    • Visser, L.E.1    Graatsma, H.H.2    Stricker, B.H.3
  • 43
    • 21044447249 scopus 로고    scopus 로고
    • The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: Comparisons, contrasts, and aspirin confounding
    • Jul;
    • Konstantinopoulos PA, Lehmann DF. The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding. J Clin Pharmacol 2005 Jul; 45 (7): 742-50
    • (2005) J Clin Pharmacol , vol.45 , Issue.7 , pp. 742-750
    • Konstantinopoulos, P.A.1    Lehmann, D.F.2
  • 44
    • 0037383122 scopus 로고    scopus 로고
    • Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis
    • Apr;
    • Singh G, Miller JD, Huse DM, et al. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003 Apr; 30 (4): 714-9
    • (2003) J Rheumatol , vol.30 , Issue.4 , pp. 714-719
    • Singh, G.1    Miller, J.D.2    Huse, D.M.3
  • 45
    • 0037196919 scopus 로고    scopus 로고
    • Case of cholestatic hepatitis with celecoxib did not fulfil international criteria [letter]
    • Mar 30;
    • Arellano FM, Zhao SZ, Reynolds MW. Case of cholestatic hepatitis with celecoxib did not fulfil international criteria [letter]. BMJ 2002 Mar 30; 324 (7340): 789
    • (2002) BMJ , vol.324 , Issue.7340 , pp. 789
    • Arellano, F.M.1    Zhao, S.Z.2    Reynolds, M.W.3
  • 46
    • 0141729308 scopus 로고    scopus 로고
    • Approaches to combat with confounding by indication in observational studies of intended drug effects
    • Oct;
    • McMahon AD. Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Saf 2003 Oct; 12 (7): 551-8
    • (2003) Pharmacoepidemiol Drug Saf , vol.12 , Issue.7 , pp. 551-558
    • McMahon, A.D.1
  • 47
    • 33947219925 scopus 로고    scopus 로고
    • Characterizing new users of NSAIDs before and after rofecoxib withdrawal
    • Oct 19;
    • Usher C, Bennett K, Teeling M, et al. Characterizing new users of NSAIDs before and after rofecoxib withdrawal. Br J Clin Pharmacol 2006 Oct 19; 63 (4): 494-7
    • (2006) Br J Clin Pharmacol , vol.63 , Issue.4 , pp. 494-497
    • Usher, C.1    Bennett, K.2    Teeling, M.3
  • 48
    • 33845603062 scopus 로고    scopus 로고
    • The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy
    • Dec;
    • Yood MU, Watkins E, Wells K, et al. The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006 Dec; 15 (12): 852-60
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , Issue.12 , pp. 852-860
    • Yood, M.U.1    Watkins, E.2    Wells, K.3
  • 49
    • 0033660965 scopus 로고    scopus 로고
    • Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding
    • Blot WJ, McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J Epidemiol Biostat 2000; 5 (2): 137-42
    • (2000) J Epidemiol Biostat , vol.5 , Issue.2 , pp. 137-142
    • Blot, W.J.1    McLaughlin, J.K.2
  • 50
    • 0036732730 scopus 로고    scopus 로고
    • NSAIDs without a prescription: Over-the-counter access, under-counted risks
    • Sep;
    • Scheiman JM, Fendrick AM. NSAIDs without a prescription: over-the-counter access, under-counted risks. Am J Gastroenterol 2002 Sep; 97 (9): 2159-61
    • (2002) Am J Gastroenterol , vol.97 , Issue.9 , pp. 2159-2161
    • Scheiman, J.M.1    Fendrick, A.M.2
  • 51
    • 0037149278 scopus 로고    scopus 로고
    • An evidence-based evaluation of the gastrointestinal safety of coxibs
    • 6A, 3D-9D, Mar 21;
    • Bombardier C. An evidence-based evaluation of the gastrointestinal safety of coxibs. Am J Cardiol 2002 Mar 21; 89 (6A): 3D-9D
    • (2002) Am J Cardiol , pp. 89
    • Bombardier, C.1
  • 52
    • 10844268967 scopus 로고    scopus 로고
    • Current approaches to prevent NSAID-induced gastropathy: COX selectivity and beyond
    • Dec;
    • Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID-induced gastropathy: COX selectivity and beyond. Br J Clin Pharmacol 2004 Dec; 58 (6): 587-600
    • (2004) Br J Clin Pharmacol , vol.58 , Issue.6 , pp. 587-600
    • Becker, J.C.1    Domschke, W.2    Pohle, T.3
  • 53
    • 38549122721 scopus 로고    scopus 로고
    • Former H. NHG-Standpunt over de preventie van NSAID-geinduceerde maagproblemen en de plaats van de coxibs in de huisartpraktijk.2004 [online]. Available from URL: http://nhg.artsennet.nl/content/resources/ AMGATE_6059_104_TICH_L1297846793/AMGATE_6059_104_TICH_R120544452391946// [Accessed 2007 May 1]
    • Former H. NHG-Standpunt over de preventie van NSAID-geinduceerde maagproblemen en de plaats van de coxibs in de huisartpraktijk.2004 [online]. Available from URL: http://nhg.artsennet.nl/content/resources/ AMGATE_6059_104_TICH_L1297846793/AMGATE_6059_104_TICH_R120544452391946// [Accessed 2007 May 1]
  • 54
    • 38549105419 scopus 로고    scopus 로고
    • National Institute of Clinical Excellence. Technology Appraisal No. 27. Guidance on use of cyclo-oxygenase (COXII) selective inhibitors celecoxib, rofecoxib, meloxicam and etodoloac for osteoarthritis and rheumatoid arthritis [online]. Available from URL: http://www.nice.org.uk/nicemedia/pdf/ coxiifullguidance.pdf [Accessed 2001 Aug 1]
    • National Institute of Clinical Excellence. Technology Appraisal No. 27. Guidance on use of cyclo-oxygenase (COXII) selective inhibitors celecoxib, rofecoxib, meloxicam and etodoloac for osteoarthritis and rheumatoid arthritis [online]. Available from URL: http://www.nice.org.uk/nicemedia/pdf/ coxiifullguidance.pdf [Accessed 2001 Aug 1]
  • 55
    • 33845457204 scopus 로고    scopus 로고
    • Risk of upper gastrointestinal ulcer bleeding associated with selective cyclooxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
    • Dec;
    • Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclooxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006 Dec; 55 (12): 1731-8
    • (2006) Gut , vol.55 , Issue.12 , pp. 1731-1738
    • Lanas, A.1    Garcia-Rodriguez, L.A.2    Arroyo, M.T.3
  • 56
    • 0027282451 scopus 로고
    • Prescriber profile and post-marketing surveillance
    • Sep 11;
    • Inman W, Pearce G. Prescriber profile and post-marketing surveillance. Lancet 1993 Sep 11; 342 (8872): 658-61
    • (1993) Lancet , vol.342 , Issue.8872 , pp. 658-661
    • Inman, W.1    Pearce, G.2
  • 57
    • 38549143063 scopus 로고    scopus 로고
    • Cleveland Clinic. Cleveland clinic launches large-scale global trial to examine cardiovascular safety of popular pain relievers. 2006 Dec 13 [online]. Available from URL: http://www.clevelandclinic.org/heartcenter/pub/news/archive/ 2005/painrelief12_13print.htm. [Accessed 2006 Dec 18]
    • Cleveland Clinic. Cleveland clinic launches large-scale global trial to examine cardiovascular safety of popular pain relievers. 2006 Dec 13 [online]. Available from URL: http://www.clevelandclinic.org/heartcenter/pub/news/archive/ 2005/painrelief12_13print.htm. [Accessed 2006 Dec 18]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.